Figure 1From: Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants Flow diagram of systematic reviews selection (left panel) and eligible randomized trials (right panel). *Concomitant diseases: depression in patients with, for example, fibromyalgia and diabetes. **Specific populations: children, pregnant women. †Specified depression: end-of-life depression, postpartum depression.Back to article page